This week, California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, convened its leadership in Washington, D.C, in order to connect biomedical industry leaders and entrepreneurs with key lawmakers in Congress.
On Jan. 25, 2019, the longest partial government shutdown in history came to an end, when President Trump announced he and bipartisan congressional leaders had reached an agreement to temporarily fund and re-open the federal government through mid-February while they continue working out a larger immigration and border security compromise.
CLSA President & CEO Mike Guerra recently discussed some of the potential impacts of the partial government shutdown on the life sciences sector with the San Diego Union-Tribune.
With the opening of the 116th Congress, California’s congressional delegation in the House of Representatives continues to rank amongst the most influential, with numerous members serving in positions of leadership and on committees with jurisdiction over issues and policies critical to the continued advancement of our state’s and the nation’s life sciences sector. Notably, California’s 46 Democratic members comprise 20% of all House Democrats – the current majority party.
The Governor’s Proposed 2019-2020 Budget Summary contained many items of interest to the life sciences industry, though it also contained some notable exclusions, such as a lack any funding for precision medicine, which had been accounted for in Governor Brown’s budget proposals from the past several years.
The Nordic Mentor Network for Entrepreneurship (NOME) joins forces with the California Life Sciences Institute (CLSI) to give Nordic Life Science startups access to potential partners and capital in one of the world’s most innovative regions.
CLSA was recently featured in the Los Angeles Business Journal regarding the organizations leadership transition.
CLSA’s 2019 California Life Sciences Industry Report was recently featured in BioSpace.
California Life Sciences Association today announced the appointment of Mike Guerra as President and CEO of CLSA effective January 7, 2019. He will succeed Sara Radcliffe, who will be departing the organization to pursue new opportunities.
CLSA’s 2019 California Life Sciences Industry Report was recently cited in the press to help capture key trends in California’s life sciences sector.